In contrast to BRCA-1 tumours, breast cancer arising from BRCA2 mutation do not differ from sporadic cancer with regard to distribution of breast cancer subtypes, the luminal forms expressing estrogen and progesterone receptors being the most frequent [24,25]. This evidence concerns the gene BRCA2 and breast cancer.